Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Van Tellingen

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1995
Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated proteinG J Zaman, J Lankelma, O van Tellingen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 1996
Isolation, purification and biological activity of major docetaxel metabolites from human fecesA Sparreboom, O Van Tellingen, E J Scherrenburg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatographyO van Tellingen, A L Sonneveldt, J H Beijnen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive daysI Wolff, K Bench, J H Beijnen, et al.
Heliyon|May 6, 2024
Fractionated brain X-irradiation profoundly reduces hippocampal immature neuron numbers without affecting spontaneous behavior in miceL E Kuil, R Seigers, M Loos, et al.
Oncogene|May 23, 2012
Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiformeT Borovski, P Beke, O van Tellingen, et al.
Anti-Cancer Drugs|January 6, 2001
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administrationM M Malingré, J H Schellens, O van Tellingen, et al.
British Journal of Cancer|April 3, 1999
Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus scheduleA Awada, C J Punt, M J Piccart, et al.
Anti-Cancer Drugs|April 9, 1999
Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion: phase I and pharmacologic studyR van Gijn, W W ten Bokkel Huinink, S Rodenhuis, et al.
Investigational New Drugs|February 25, 2009
Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out miceJ H Beumer, N E Franke, R Tolboom, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1995
Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated proteinG J Zaman, J Lankelma, O van Tellingen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 1996
Isolation, purification and biological activity of major docetaxel metabolites from human fecesA Sparreboom, O Van Tellingen, E J Scherrenburg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatographyO van Tellingen, A L Sonneveldt, J H Beijnen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive daysI Wolff, K Bench, J H Beijnen, et al.
Heliyon|May 6, 2024
Fractionated brain X-irradiation profoundly reduces hippocampal immature neuron numbers without affecting spontaneous behavior in miceL E Kuil, R Seigers, M Loos, et al.
Oncogene|May 23, 2012
Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiformeT Borovski, P Beke, O van Tellingen, et al.
Anti-Cancer Drugs|January 6, 2001
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administrationM M Malingré, J H Schellens, O van Tellingen, et al.
British Journal of Cancer|April 3, 1999
Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus scheduleA Awada, C J Punt, M J Piccart, et al.
Anti-Cancer Drugs|April 9, 1999
Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion: phase I and pharmacologic studyR van Gijn, W W ten Bokkel Huinink, S Rodenhuis, et al.
Investigational New Drugs|February 25, 2009
Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out miceJ H Beumer, N E Franke, R Tolboom, et al.
Pageof 10